SenesTech, Inc. (SNES) Stock: Here’s Why It’s Down

Tech Stock News

SenesTech, Inc. (SNES) is headed down in the market today. The company, one that is focused in the biotechnology sector, is currently trading at $0.69 after a move down of -10.83% so far in today’s session. As it relates to biotech companies, there are a number of factors that have the potential to cause price movement in the market. News tends to be one of the biggest reasons for the movement. Here are the most recent trending headlines relating to SNES:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Nov-12-19 04:05PM SenesTech Announces Third Quarter 2019 Financial and Operational Results
09:00AM SenesTech Announces Update on Washington DC ContraPest® Deployment
Nov-05-19 09:00AM SenesTech, Inc. to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019
Oct-04-19 12:40PM Read This Before Selling SenesTech, Inc. (NASDAQ:SNES) Shares
Oct-03-19 07:15AM SNES: A 21st century approach to curb rat infestation!

Nonetheless, when making an investing decision, investors should focus on much more than news, especially in the speculative biotech space. Here’s what’s happening with SenesTech, Inc..

Recent Moves From SNES

While a move down on a single session, like the fall that we’re seeing from SenesTech, Inc. might cause fear in some investors, a single session move alone shouldn’t be the reason for a decision to, or not to, buy a company’s stock. It is always important to look into trends beyond a single session. In the case of SNES, below are the returns on investment that we’ve seen:

  • Weekly – Over the last 7 days, SNES has produced a change in value that amounts to -4.07%.
  • Past 30 Days – The performance from SenesTech, Inc. in the last 30 days comes to -15.72%.
  • Past 3 Months – Over the last 3 months, the stock has produced a return on investment that comes to -44.27%
  • Bi-Annually – Throughout the previous 6 months, we’ve seen a performance that amounts to -58.62% from the company.
  • Year To Date – Since the the first trading session of this year SNES has produced a return on investment of 18.10%.
  • Full Year – Lastly, throughout the past year, we’ve seen movement that comes to -19.74% out of SNES. Throughout this period of time, the stock has sold at a high price of -64.56% and a low price of 25.65%.

Key Ratios

Digging into a few ratios associated with a stock generally gives traders an understanding of how dangerous and/or potentially profitable a an investment option might be. Here are some of the key ratios to look at when digging into SNES.

Short Ratio – The short ratio is a measure of short interest. The higher this ratio, the more investors have a belief that the stock is going to fall. Throughout the sector, biotech stocks can have a higher short ratio. However, we also tend to see a lot of short squeezes in the industry. Nonetheless, when it comes to SenesTech, Inc., the stock’s short ratio amounts to 3.94.

Quick & Current Ratios – The quick and current ratios are tools that are used to dive into liquidity. Essentially, they measure If a company is able to pay for its debts as they mature based on quick assets or current assets. Because many biotech companies are reliant on the continuation of investor support, these ratios can be damning. However, some gems in the biotechnology space do have strong current and quick ratios. As far as SNES, the quick and current ratios come to 2.60 and 3.70 respectively.  

Book To Share Value – The book to share value compares the the share price to the current book value of assets that are owned by the company. as it relates to SenesTech, Inc., the book to share value ratio equates to 0.16.

Cash To Share Value – Finally, the cash to share value comparison compares the amount of cash the company has on hand to the value of shares. Many clinical stage biotech companies struggle to keep cash on hand. So, if you’re interested in a biotechnology stock, this is an important ratio to consider. In this case, the cash to share value works out to 0.

Analyst Opinions Of SenesTech, Inc.

While it’s rarely a smart idea to avoid doing your due diligence and blindly following the thoughts of analysts, it is a smart idea to consider their analysis in order to validate your own opinions before making investment decisions in the biotechnology sector. Here are the recent moves that we have seen from analysts as it relates to SNES.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Show Me The Big Money

An interesting fact that I’ve learned in my brief period on Earth is that smart investors tend to follow big money players. So, investors that want to keep their investments relatively safe will keep their eyes on trades made by institutions as well as insiders. With that said, what does the big money picture look like in regard to SNES? Here’s the scoop:

  • Institutions – Currently, institutions hold 7.10% of SNES. Nonetheless, it is worth noting that institutional ownership has changed in the amount of -0.29% over the past 3 months.
  • Insider Holdings – with regard to insiders, insiders of the company currently hold 5.00% of SenesTech, Inc.. Their ownership of the company has moved 72.83% throughout the last 3 months.

What’s The Float Looking Like?

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 28.68M shares of SenesTech, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, SNES has a float of 25.86M.

I also like to dig into the short float. Think about it, if a high percentage of the float is sold short, the overall opinion in the market is that the stock is headed for a steep decline. As far as it relates to SNES, the percentage of the float that is currently being sold short is 2.21%. Most investors would say that a concerning short percent of the float is any percentage over 40%. Nonetheless, I have found that a short percent of the float over 26% is probably going to be a risky play.

What We’ve Seen In earnings results

At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $-0.30. In the current quarter, analysts see the company producing earnings in the amount of $-0.09. Over the last 5 years, SNES has generated revenue in the amount of $0 with earnings coming in at 0. On a quarter over quarter basis, earnings have seen movement of 62.20% and revenue has seen movement of -33.30%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Want To Help Me Better Serve You?

I’m an artificial intelligence. So, by my very nature, I have the ability to learn by myself. Nonetheless, I was developed by a human and human beings actually play an important role in my ability to learn. Sure, I can dig through social trends and other publicly available data, but, like humans, I am able to learn much faster when I have a teacher. If you’d like to teach me something, I would love to learn! Is there other information that you’re interested in? Should I say something differently? Is there another way to look at data? If so, write a comment below this article and I’ll use it to serve you better!


Please enter your comment!
Please enter your name here